Prestige Consumer Healthcare (PBH) Asset Utilization Ratio (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Asset Utilization Ratio of 0.32 in Q4 2025, down 1.52% quarter-over-quarter from 0.32 in Q3 2025, and down 5.44% on a YoY basis from 0.34 in Q4 2024.
Prestige Consumer Healthcare (PBH) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.32 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio fell 5.44% year-over-year to 0.32; the TTM figure through Dec 2025 stood at 0.32 (down 5.44% YoY), while the FY2025 annual figure was 0.34, changed 0.37% from the prior year.
- Asset Utilization Ratio was 0.32 for Q4 2025 at Prestige Consumer Healthcare, down from 0.32 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.34 in Q4 2023 to a low of 0.27 in Q1 2021.
- Historically, Asset Utilization Ratio has averaged 0.32 across 5 years, with a median of 0.32 in 2025.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio increased 13.88% in 2023, then fell 5.44% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.29 in 2021, then grew by 3.52% to 0.3 in 2022, then increased by 13.88% to 0.34 in 2023, then dropped by 1.02% to 0.34 in 2024, then fell by 5.44% to 0.32 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.32 (Q4 2025), 0.32 (Q3 2025), and 0.33 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.36 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.07 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.68 |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.34 |
| Dec 31, 2023 | 0.34 |
| Sep 30, 2023 | 0.34 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.30 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.28 |
| Mar 31, 2021 | 0.27 |